Tag: generic substitution

Antitrust Issues in Generic Substitution: How Big Pharma Blocks Cheaper Drugs

Big Pharma uses legal tricks like product hopping and REMS abuse to block generic drugs from reaching patients, even when state laws allow substitution. These antitrust violations cost U.S. consumers billions annually.

read more

Global Perspectives on Generics: How Countries Are Cutting Drug Costs Without Compromising Care

Explore how countries like the U.S., China, India, and South Korea use generic drugs to cut healthcare costs - and the hidden risks of pushing prices too low. Learn what policies work, what fails, and why quality matters.

read more